929360081000036101: Medicinal product pack reference set (foundation metadata concept)

SNOMED CT Concept\SNOMED CT Model Component\Foundation metadata concept\Reference set\Simple type reference set\Medicinal product pack reference set

Status: current, Primitive. Date: 31-Mar 2011. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module

3288201000168119 MPP (medicinal product pack) reference set en Synonym Active Case sensitive Australian Medicines Terminology module

965507131000036117 Medicinal product pack reference set en Synonym Active Case sensitive Australian Medicines Terminology module

965507141000036110 Medicinal product pack reference set (foundation metadata concept) en Fully specified name Active Case sensitive Australian Medicines Terminology module

4351131000168114 <p>Terminology to describe in a health record an abstract concept representing the properties of one or more quantitatively and clinically equivalent Trade Product Packs.</p><p>This reference set supports the accurate and unambiguous electronic communication and exchange of medicines information between clinicians for medication management and the recording of adverse reactions.</p><p><b>Target client: </b>NCTS</p> en Definition Active Case sensitive Australian Medicines Terminology module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Medicinal product pack reference set	Has licence	SNOMED CT-AU licence	true	Inferred relationship	Some	1740441059
Medicinal product pack reference set	Developed by	Australian Digital Health Agency	true	Inferred relationship	Some	991480534
Medicinal product pack reference set	Is a	Simple type reference set	true	Inferred relationship	Some

Members

anastrozole 1 mg tablet, 300 tablets (medicinal product pack)

anastrozole 1 mg tablet, 50

anastrozole 1 mg tablet, 500

anastrozole 1 mg tablet, 56

anastrozole 1 mg tablet, 60

anastrozole 1 mg tablet, 84

anastrozole 1 mg tablet, 90 tablets (medicinal product pack)

anastrozole 1 mg tablet, 98

ancestim 1.875 mg injection, 3 vials

anecortave acetate 15 mg/0.5 mL injection, 0.5 mL vial

anidulafungin 100 mg injection, 1 vial

anifrolumab 300 mg/2 mL injection, 2 mL vial

naphazoline hydrochloride 0.05% + antazoline phosphate 0.5% eye drops, 15 mL

naphazoline nitrate 0.025% + antazoline sulfate 0.5% eye drops, 10 mL

anti-D rho immunoglobulin 1500 units/2 mL injection, 2 mL syringe

anti-D rho immunoglobulin 250 units injection, 1 vial

anti-D rho immunoglobulin 600 units injection [1 vial] (&) inert substance diluent [2.5 mL vial], 1 pack

anti-D rho immunoglobulin 625 units injection, 1 vial

antimony trisulfide 1.1 mg/mL injection [1 mL vial] (&) monobasic sodium phosphate dihydrate 6.1 mg/mL + dibasic sodium phosphate 49 mg/mL injection [1 mL vial] (&) hydrochloric acid 1 Molar injection [1 mL vial], 1 pack

antimony trisulfide 1.1 mg/mL injection, 1 mL vial

antithrombin III 1000 units injection [1 vial] (&) inert substance diluent [20 mL vial], 1 pack

antithymocyte immunoglobulin equine 250 mg/5 mL injection, 5 mL ampoule

antithymocyte immunoglobulin equine 250 mg/5 mL injection, 5 x 5 mL ampoules

antithymocyte immunoglobulin rabbit 20 mg/mL injection, 10 mL vial

antithymocyte immunoglobulin rabbit 20 mg/mL injection, 5 mL vial

antithymocyte immunoglobulin rabbit 20 mg/mL injection, 10 x 10 mL vials

antithymocyte immunoglobulin rabbit 20 mg/mL injection, 10 x 5 mL vials

antithymocyte immunoglobulin rabbit 25 mg injection, 1 vial

apalutamide 60 mg tablet, 120

apixaban 2.5 mg tablet, 10

apixaban 2.5 mg tablet, 100

apixaban 2.5 mg tablet, 14

apixaban 2.5 mg tablet, 20

apixaban 2.5 mg tablet, 30

apixaban 2.5 mg tablet, 60

apixaban 5 mg tablet, 100

apixaban 5 mg tablet, 112

apixaban 5 mg tablet, 120

apixaban 5 mg tablet, 14

apixaban 5 mg tablet, 168

apixaban 5 mg tablet, 20

apixaban 5 mg tablet, 28

apixaban 5 mg tablet, 56

apixaban 5 mg tablet, 60

apomorphine hydrochloride hemihydrate 10 mg/mL injection, 5 x 1 mL ampoules

apomorphine hydrochloride hemihydrate 100 mg/20 mL injection, 20 mL vial

apomorphine hydrochloride hemihydrate 100 mg/20 mL injection, 10 x 20 mL vials

apomorphine hydrochloride hemihydrate 100 mg/20 mL injection, 5 x 20 mL vials

apomorphine hydrochloride hemihydrate 20 mg/2 mL injection, 5 x 2 mL ampoules

apomorphine hydrochloride hemihydrate 30 mg/3 mL injection, 5 x 3 mL cartridges

apomorphine hydrochloride hemihydrate 30 mg/3 mL injection, 5 x 3 mL pen devices

apomorphine hydrochloride hemihydrate 50 mg/10 mL injection, 5 x 10 mL syringes

apomorphine hydrochloride hemihydrate 50 mg/5 mL injection, 5 mL ampoule

apomorphine hydrochloride hemihydrate 50 mg/5 mL injection, 10 x 5 mL ampoules

apomorphine hydrochloride hemihydrate 50 mg/5 mL injection, 5 x 5 mL ampoules

apraclonidine 0.5% eye drops, 10 mL

apraclonidine 0.5% eye drops, 2.5 mL

apraclonidine 0.5% eye drops, 5 mL

apremilast 10 mg tablet [4] (&) apremilast 20 mg tablet [4] (&) apremilast 30 mg tablet [19], 27

apremilast 30 mg tablet, 168

apremilast 30 mg tablet, 56

aprepitant 125 mg capsule [1] (&) aprepitant 80 mg capsule [2], 3

aprepitant 125 mg capsule, 1

aprepitant 165 mg capsule, 1

aprepitant 40 mg capsule, 1 capsule (medicinal product pack)

aprepitant 80 mg capsule, 1

aprepitant 80 mg capsule, 2

aprotinin 1 000 000 KI units/100 mL injection, 100 mL vial

aprotinin 2 000 000 KI units/200 mL injection, 200 mL vial

aprotinin 2250 KI units/mL + factor XIII 1.2 units/mL + fibrinogen 72 mg/mL solution [1 mL chamber] (&) human thrombin 3.2 units/mL + calcium chloride dihydrate 5.292 mg/mL solution [1 mL chamber], 2 mL dual chamber syringe

aprotinin 2250 KI units/mL + factor XIII 1.2 units/mL + fibrinogen 72 mg/mL solution [1 mL chamber] (&) human thrombin 400 units/mL + calcium chloride dihydrate 5.292 mg/mL solution [1 mL chamber], 2 mL dual chamber syringe

aprotinin 2250 KI units/mL + factor XIII 1.2 units/mL + fibrinogen 72 mg/mL solution [2 mL chamber] (&) human thrombin 3.2 units/mL + calcium chloride dihydrate 5.292 mg/mL solution [2 mL chamber], 4 mL dual chamber syringe

aprotinin 2250 KI units/mL + factor XIII 1.2 units/mL + fibrinogen 72 mg/mL solution [2 mL chamber] (&) human thrombin 400 units/mL + calcium chloride dihydrate 5.292 mg/mL solution [2 mL chamber], 4 mL dual chamber syringe

aprotinin 2250 KI units/mL + factor XIII 1.2 units/mL + fibrinogen 72 mg/mL solution [5 mL chamber] (&) human thrombin 3.2 units/mL + calcium chloride dihydrate 5.292 mg/mL solution [5 mL chamber], 10 mL dual chamber syringe

aprotinin 2250 KI units/mL + factor XIII 1.2 units/mL + fibrinogen 72 mg/mL solution [5 mL chamber] (&) human thrombin 400 units/mL + calcium chloride dihydrate 5.292 mg/mL solution [5 mL chamber], 10 mL dual chamber syringe

aprotinin 3000 KI units/mL + calcium chloride dihydrate 4.4 mg/mL + factor XIII 10 units/mL + fibrinogen 70 mg/mL + fibronectin 2 mg/mL + human thrombin 350 units/mL solution, 10 mL

aprotinin 3000 KI units/mL + calcium chloride dihydrate 4.4 mg/mL + factor XIII 10 units/mL + fibrinogen 70 mg/mL + fibronectin 2 mg/mL + human thrombin 350 units/mL solution, 2 mL

aprotinin 3000 KI units/mL + calcium chloride dihydrate 4.4 mg/mL + factor XIII 10 units/mL + fibrinogen 70 mg/mL + fibronectin 2 mg/mL + human thrombin 350 units/mL solution, 4 mL

aprotinin 500 000 KI units/50 mL injection, 50 mL vial

salicylic acid 2% + precipitated sulfur 2% + aqueous cream, 100 g

salicylic acid 3% + precipitated sulfur 3% + aqueous cream, 100 g

salicylic acid 2% + aqueous cream, 100 g

salicylic acid 3% + aqueous cream, 100 g

salicylic acid 5% + aqueous cream, 100 g

aqueous cream, 1 L

aqueous cream, 10 kg

aqueous cream, 100 g

aqueous cream, 325 mL

aqueous cream, 500 g

aqueous cream, 500 mL

arachidonic acid and docosahexaenoic acid with carbohydrate containing 200 mg arachidonic acid and 100 mg docosahexaenoic acid powder for oral liquid, 30 x 4 g sachets

ortho-dichlorobenzene 14% + para-dichlorobenzene 2% + chlorobutanol hemihydrate 5% + arachis oil 57% ear drops, 10 mL

arachis oil extract of coal tar 0.3% + cade oil 0.3% + coal tar solution 0.1% + tar 0.3% shampoo, 300 mL

argatroban 250 mg/2.5 mL injection, 1 x 2.5 mL vial

argatroban monohydrate 100 mg/mL injection, 1 x 2.5 mL vial

argatroban monohydrate 100 mg/mL injection, 6 x 2.5 mL vials

arginine 750 mg capsule, 250

arginine hydrochloride 60% (15 g/25 mL) injection, 10 x 25 mL vials

arginine with carbohydrate containing 2 g arginine powder for oral liquid, 30 x 4 g sachets

arginine with carbohydrate containing 5 g arginine powder for oral liquid, 30 x 7.6 g sachets

arginine with carbohydrate containing 500 mg arginine powder for oral liquid, 30 x 4 g sachets

Start Previous Page 15 of 160 Next End

Reference Sets

Reference set descriptor